S Y Ha Selected Research

S Y Ha Research Topics

Disease

3	Neoplasms (Cancer) 01/2020 - 07/2004
3	Thalassemia 07/2017 - 08/2004
2	Infections 01/2020 - 08/2004
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 10/2016 - 07/2001
2	beta-Thalassemia (Cooley's Anemia) 08/2004 - 11/2000
2	alpha-Thalassemia 07/2001 - 08/2000
1	Hyperbilirubinemia 01/2022
1	Hemolytic Anemia 01/2022
1	Splenomegaly 01/2022
1	Hemoglobinopathies 01/2022
1	Hydrops Fetalis (Fetal Edema) 09/2021
1	Gastritis 01/2020
1	Melanoma (Melanoma, Malignant) 01/2020
1	Opportunistic Infections (Opportunistic Infection) 01/2020
1	Respiratory Insufficiency (Respiratory Failure) 01/2018
1	Orthostatic Hypotension (Postural Hypotension) 08/2016
1	Orthostatic Intolerance 08/2016
1	Postural Orthostatic Tachycardia Syndrome 08/2016
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 02/2016
1	Neuroblastoma 01/2016
1	Post-Dural Puncture Headache 09/2014
1	Hemorrhage 03/2012
1	Heart Failure 08/2011
1	Weight Gain 11/2007
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 11/2007
1	Pleural Effusion (Pleural Effusions) 11/2007
1	Atherosclerosis 12/2006
1	Jaundice (Icterus) 10/2005
1	Gallstones (Gallstone) 10/2005
1	Wounds and Injuries (Trauma) 08/2004
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 07/2004
1	Retinoblastoma (Glioblastoma, Retinal) 07/2004
1	13q deletion syndrome 07/2004
1	Left Ventricular Dysfunction 06/2003
1	Hyperemia 11/2002
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2002
1	Hepatoblastoma 02/2002
1	Hepatocellular Carcinoma (Hepatoma) 02/2002
1	Rupture 02/2002

Drug/Important Bio-Agent (IBA)

5	IronIBA 08/2011 - 11/2002
2	Hemoglobins (Hemoglobin)IBA 01/2022 - 10/2005
2	hemoglobin Bart'sIBA 09/2021 - 07/2001
2	BilirubinIBA 11/2007 - 10/2005
2	Ferritins (Ferritin)IBA 10/2005 - 08/2000
2	alpha-GlobinsIBA 10/2005 - 08/2000
1	hemoglobin HammersmithIBA 01/2022
1	Ganciclovir (Cytovene)FDA LinkGeneric 01/2020
1	pembrolizumabIBA 01/2020
1	Antiviral Agents (Antivirals)IBA 01/2020
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2020
1	Inosine Triphosphate (ITP)IBA 10/2016
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 10/2016
1	hydroxide ionIBA 08/2016
1	Clofarabine (Clolar)FDA Link 02/2016
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2016
1	Etoposide (VP 16)FDA LinkGeneric 02/2016
1	Proteins (Proteins, Gene)FDA Link 09/2014
1	Glucose (Dextrose)FDA LinkGeneric 09/2014
1	SteroidsIBA 03/2012
1	Anesthetics (Anesthetic Agents)IBA 03/2012
1	DeferiproneIBA 08/2011
1	Anti-Bacterial Agents (Antibiotics)IBA 08/2004
1	Dobutamine FDA LinkGeneric 06/2003
1	Nitroglycerin (Dynamite)FDA LinkGeneric 11/2002
1	Surface Antigens (Surface Antigen)IBA 02/2002
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 02/2002
1	gamma-Globulins (gamma-Globulin)IBA 07/2001
1	beta-Globins (beta Globin)IBA 11/2000
1	NucleotidesIBA 11/2000
1	Hemoglobin HIBA 08/2000

Therapy/Procedure

4	Hematopoietic Stem Cell Transplantation 01/2022 - 11/2007
4	Therapeutics 01/2020 - 07/2004
3	Stem Cell Transplantation 02/2016 - 07/2004
2	Drug Therapy (Chemotherapy) 01/2016 - 02/2002
1	Homologous Transplantation 09/2021
1	Immunotherapy 01/2020
1	Intrauterine Blood Transfusion 01/2018
1	Artificial Respiration (Mechanical Ventilation) 01/2018
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2016
1	Punctures 09/2014
1	General Anesthesia 03/2012
1	Tonsillectomy 03/2012
1	Hysterectomy 07/2006
1	Chelation Therapy (Therapy, Chelation) 08/2004
1	Subcutaneous Infusions 08/2004
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 07/2004